AdvaMed

Never underestimate the value of mentorship, the power of a sense of belonging, and an open mind to ideas from people of various backgrounds and walks of life. These attributes are critical to bringing new initiatives to the forefront and in the case of #medtech, to serve patients with lifesaving, life-changing technology. AdvaMed is proud to share the story of a medtech entrepreneur who received just the warm welcome she needed to bring her smart idea into fruition. We wish Maria Artunduaga and her company, Samay, every success. Read more:

AdvaMed is proud to have supported a new Massachusetts bill that goes into effect in 2025. The bill will ensure all insurance covers both routine breast cancer screenings and follow-up exams for those who need them without increasing patient cost-sharing. Nearly half of all women 40 and older who get mammograms are found to have dense breast tissue and may need supplemental screening. Insurance too often doesn’t cover the supplemental screening, leaving women in a difficult position. The concern is especially pressing for Black women, who have increased likelihood of dense breast tissue, later cancer diagnoses, and higher death rates than white women. Thank you, Governor Healey, for prioritizing women's health and saving patients' lives. https://lnkd.in/eiHjisfz

Hannah's experience underscores the life-changing role of diabetes #medtech in managing blood sugar levels. Continuous glucose monitors and connected insulin pumps are empowering people to take control of their diabetes with confidence, reducing their burden of constant manual checking and helping them avoid potentially dangerous complications. This #NationalDiabetesMonth, learn more about how #medtech is transforming lives to help #BeatDiabetes. https://lnkd.in/epJw2rZG

AdvaMed is proud to share the inspiring efforts of our member companies as they launch their powerful diabetes campaigns in honor of #NationalDiabetesMonth. Today, we recognize embecta’s “People First” initiative, which celebrates individuals living with diabetes and works to champion their individuality and well-being as people with unique personalities, passions, and dreams. By recognizing diabetes as just one part of a person’s life, this campaign emphasizes the importance for all of us not to lose sight that people with diabetes are people first. Join us this month in celebrating the resilience and strength of people living with diabetes and learn more about these advocacy efforts!

AdvaMed and our member companies are proud to stand with our partner organizations to promote #WorldDiabetesDay. Organizations like Breakthrough T1D are focused on accelerating the development of life-changing medical technologies and advancing research to improve the lives of those living with Type 1 diabetes. Learn more about their incredible impact on patients’ lives: https://lnkd.in/gfBjJafb

In honor of #NationalDiabetesMonth, we’re featuring as the #DeviceoftheWeek Abbott's world-leading FreeStyle Libre continuous glucose monitoring (CGM) systems, used by more than 6 million people across 60 countries. Libre systems include a sensor, which is applied to the back of the arm for up to 15 days, that sends automatic, minute-by-minute glucose readings to a mobile app or reader. Previously, people with diabetes were required to check their glucose levels several times a day through painful fingersticks. With Libre, checking glucose is as simple as reading a number on a smartphone app, making it much easier for individuals to take action, such as taking insulin or adjusting food and activity, and make progress toward their health goals. Ten years after its initial launch, Libre technology continues to help make #diabetes care easier and more accessible for more people. Learn about how Abbott is a #medtech leader in providing solutions that improve the lives of millions of those living with diabetes. https://bit.ly/3Z0m4iE

On this #VeteransDay, AdvaMed honors all those who have served and sacrificed for our country. Read more about how organizations like?MedTechVets is giving back to the veteran community by helping veterans find meaningful employment in the #medtech industry.

Millions of Medicare beneficiaries will have coverage of important diagnostic tools and certain digital therapeutics for mental health treatment, thanks to CMS coverage decisions for 2025. CMS recognized two expandingly popular, valuable imaging technologies: diagnostic radiopharmaceuticals used to diagnose illnesses including Alzheimer’s, Parkinson’s, heart disease, and certain types of cancer; and computed tomography colonography (CTC), also known as a virtual colonoscopy, to provide Medicare beneficiaries access to a minimally invasive colorectal cancer screening tool. With its digital therapeutics decision, CMS opened a conversation on the types of these treatments to cover for Medicare beneficiaries, a critical step as digital treatments arise that could improve mental health conditions in addition to traditional methods. Kudos to CMS for forward-looking action helping Medicare beneficiaries achieve better health. Read more: https://lnkd.in/ettpvcMn

The number-one cancer women in the U.S. are diagnosed with is breast cancer. And at least half of those women have what doctors and scientists call “dense breast tissue,” which often means initial screening options can miss signs of cancer. AdvaMed is calling on Medicare to expand its coverage?to include supplemental imaging for women with dense breast tissue, emphasizing its life-saving potential. AdvaMed highlights the critical health equity needs this coverage would address, particularly as many women face barriers such as lack of insurance coverage of or limited access to recommended supplemental screenings. Black women, for example, have higher mortality rates with respect to breast cancer. AdvaMed supports efforts such as the bipartisan?Find It Early Act, pending in Congress,?and calls on CMS to take the life-saving step of ensuring equitable access to vital imaging technologies for the millions of women in Medicare at risk of breast cancer. https://lnkd.in/eGNwA2Ud

AdvaMed was a proud sponsor of Breakthrough T1D's annual Mid-Atlantic Hope Gala. This event promoted the research necessary to develop the life-saving and life-improving medical technology that allows millions of patients living with Type 1 Diabetes to live healthier lives. #NationalDiabetesMonth